Hartman, Zachary C <br/><br/>
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2010 
 - 1466-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-2549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae<br/>Animals<br/>Blotting, Western<br/>Cancer Vaccines--immunology<br/>Cell Separation<br/>Female<br/>Flow Cytometry<br/>Genes, erbB-2--genetics<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Humans<br/>Mammary Neoplasms, Experimental--genetics<br/>Mice<br/>Mice, Transgenic<br/>Oligonucleotide Array Sequence Analysis<br/>Receptor, ErbB-2--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Vaccination--methods